Skip to main content
Top
Published in: Pediatric Radiology 12/2014

01-12-2014 | Pictorial Essay

Extracardiac applications of MR blood pool contrast agent in children

Authors: Shannon G. Farmakis, Geetika Khanna

Published in: Pediatric Radiology | Issue 12/2014

Login to get access

Abstract

Magnetic resonance (MR) angiography has significantly reduced the need for diagnostic conventional angiography and is preferred over CT angiography in children because of its lack of ionizing radiation. The availability of gadofosveset trisodium (the only clinically approved blood pool MR contrast agent) has led to an increase in applications of MR for vascular imaging and an improvement in diagnostic quality of MR angiography. Gadofosveset is a gadolinium-based contrast agent that binds reversibly to albumin, resulting in increased paramagnetic effect and longer intravascular residence. This allows for high-resolution arterial and venous MR angiography, assessment of flow characteristics of vascular malformations, dynamic vascular imaging, and multi-station imaging with a single low-dose gadolinium contrast injection. The purpose of this pictorial essay is to facilitate understanding of the kinetics and safety profile of gadofosveset trisodium, discuss technical aspects of imaging, and illustrate advantages and extracardiac applications in pediatric body imaging.
Literature
2.
go back to reference Parmelee DJ, Walovitch RC, Ouellet HS et al (1997) Preclinical evaluation of the pharmacokinetics, biodistribution, and elimination of MS-325, a blood pool agent for magnetic resonance imaging. Invest Radiol 32:741–747PubMedCrossRef Parmelee DJ, Walovitch RC, Ouellet HS et al (1997) Preclinical evaluation of the pharmacokinetics, biodistribution, and elimination of MS-325, a blood pool agent for magnetic resonance imaging. Invest Radiol 32:741–747PubMedCrossRef
3.
go back to reference Grist TM, Korosec FR, Peters DC et al (1998) Steady-state and dynamic MR angiography with MS-325: initial experience in humans. Radiology 207:539–544PubMedCrossRef Grist TM, Korosec FR, Peters DC et al (1998) Steady-state and dynamic MR angiography with MS-325: initial experience in humans. Radiology 207:539–544PubMedCrossRef
5.
go back to reference Caravan P, Cloutier NJ, Greenfield MT et al (2002) The interaction of MS-325 with human serum albumin and its effect on proton relaxation rates. J Am Chem Soc 124:3152–3162PubMedCrossRef Caravan P, Cloutier NJ, Greenfield MT et al (2002) The interaction of MS-325 with human serum albumin and its effect on proton relaxation rates. J Am Chem Soc 124:3152–3162PubMedCrossRef
6.
go back to reference Perreault P, Edelman MA, Baum RA et al (2003) MR angiography with gadofosveset trisodium for peripheral vascular disease: phase II trial. Radiology 229:811–820PubMedCrossRef Perreault P, Edelman MA, Baum RA et al (2003) MR angiography with gadofosveset trisodium for peripheral vascular disease: phase II trial. Radiology 229:811–820PubMedCrossRef
7.
go back to reference Bremerich J, Bilecen D, Reimer P (2007) MR angiography with blood pool contrast agents. Eur Radiol 17:3017–3024PubMedCrossRef Bremerich J, Bilecen D, Reimer P (2007) MR angiography with blood pool contrast agents. Eur Radiol 17:3017–3024PubMedCrossRef
8.
go back to reference Shamsi K, Yucel EK, Chamberlin P (2006) A summary of safety of gadofosveset (MS-325) at 0.03 mmol/kg body weight dose: phase II and phase III clinical trials data. Invest Radiol 41:822–830PubMedCrossRef Shamsi K, Yucel EK, Chamberlin P (2006) A summary of safety of gadofosveset (MS-325) at 0.03 mmol/kg body weight dose: phase II and phase III clinical trials data. Invest Radiol 41:822–830PubMedCrossRef
9.
go back to reference Rigsby C, Popescu A, Boylan E et al (2014) Safety of a blood pool contrast agent in children and young adults. Pediatr Radiol 44:S81CrossRef Rigsby C, Popescu A, Boylan E et al (2014) Safety of a blood pool contrast agent in children and young adults. Pediatr Radiol 44:S81CrossRef
10.
go back to reference Prince MR, Pearson GD, Zhang HL et al (2010) Advantages of blood pooling in pediatric MR angiography. JACC Cardiovasc Imaging 3:514–516PubMedCrossRef Prince MR, Pearson GD, Zhang HL et al (2010) Advantages of blood pooling in pediatric MR angiography. JACC Cardiovasc Imaging 3:514–516PubMedCrossRef
11.
go back to reference Zou Z, Zhang HL, Roditi GH et al (2011) Nephrogenic systemic fibrosis: review of 370 biopsy-confirmed cases. JACC Cardiovasc Imaging 4:1206–1216PubMedCrossRef Zou Z, Zhang HL, Roditi GH et al (2011) Nephrogenic systemic fibrosis: review of 370 biopsy-confirmed cases. JACC Cardiovasc Imaging 4:1206–1216PubMedCrossRef
12.
go back to reference Sabach AS, Bruno M, Kim D et al (2013) Gadofosveset trisodium: abdominal and peripheral vascular applications. AJR Am J Roentgenol 200:1378–1386PubMedCrossRef Sabach AS, Bruno M, Kim D et al (2013) Gadofosveset trisodium: abdominal and peripheral vascular applications. AJR Am J Roentgenol 200:1378–1386PubMedCrossRef
13.
go back to reference Kim CY, Heye T, Bashir MR et al (2013) Gadofosveset-enhanced magnetic resonance angiography of the thoracic vasculature in the equilibrium phase: feasibility and impact of dose. J Comput Assist Tomogr 37:732–736PubMedCrossRef Kim CY, Heye T, Bashir MR et al (2013) Gadofosveset-enhanced magnetic resonance angiography of the thoracic vasculature in the equilibrium phase: feasibility and impact of dose. J Comput Assist Tomogr 37:732–736PubMedCrossRef
14.
go back to reference Goyen M, Edelman M, Perreault P et al (2005) MR angiography of aortoiliac occlusive disease: a phase III study of the safety and effectiveness of the blood-pool contrast agent MS-325. Radiology 236:825–833PubMedCrossRef Goyen M, Edelman M, Perreault P et al (2005) MR angiography of aortoiliac occlusive disease: a phase III study of the safety and effectiveness of the blood-pool contrast agent MS-325. Radiology 236:825–833PubMedCrossRef
15.
go back to reference Haneder S, Attenberger UI, Biffar A et al (2011) Gadofosveset: parameter optimization for steady-state imaging of the thoracic and abdominal vasculature. Invest Radiol 46:678–685PubMed Haneder S, Attenberger UI, Biffar A et al (2011) Gadofosveset: parameter optimization for steady-state imaging of the thoracic and abdominal vasculature. Invest Radiol 46:678–685PubMed
16.
go back to reference Klessen C, Hein PA, Huppertz A et al (2007) First-pass whole-body magnetic resonance angiography (MRA) using the blood-pool contrast medium gadofosveset trisodium: comparison to gadopentetate dimeglumine. Invest Radiol 42:659–664PubMedCrossRef Klessen C, Hein PA, Huppertz A et al (2007) First-pass whole-body magnetic resonance angiography (MRA) using the blood-pool contrast medium gadofosveset trisodium: comparison to gadopentetate dimeglumine. Invest Radiol 42:659–664PubMedCrossRef
17.
go back to reference Maki JH, Wang M, Wilson GJ et al (2009) Highly accelerated first-pass contrast-enhanced magnetic resonance angiography of the peripheral vasculature: comparison of gadofosveset trisodium with gadopentetate dimeglumine contrast agents. J Magn Reson Imaging 30:1085–1092PubMedCrossRef Maki JH, Wang M, Wilson GJ et al (2009) Highly accelerated first-pass contrast-enhanced magnetic resonance angiography of the peripheral vasculature: comparison of gadofosveset trisodium with gadopentetate dimeglumine contrast agents. J Magn Reson Imaging 30:1085–1092PubMedCrossRef
18.
go back to reference Hadizadeh DR, Gieseke J, Lohmaier SH et al (2008) Peripheral MR angiography with blood pool contrast agent: prospective intraindividual comparative study of high-spatial-resolution steady-state MR angiography versus standard-resolution first-pass MR angiography and DSA. Radiology 249:701–711PubMedCrossRef Hadizadeh DR, Gieseke J, Lohmaier SH et al (2008) Peripheral MR angiography with blood pool contrast agent: prospective intraindividual comparative study of high-spatial-resolution steady-state MR angiography versus standard-resolution first-pass MR angiography and DSA. Radiology 249:701–711PubMedCrossRef
19.
go back to reference Vasanawala SS, Chan FP, Newman B et al (2011) Combined respiratory and cardiac triggering improves blood pool contrast-enhanced pediatric cardiovascular MRI. Pediatr Radiol 41:1536–1544PubMedCentralPubMedCrossRef Vasanawala SS, Chan FP, Newman B et al (2011) Combined respiratory and cardiac triggering improves blood pool contrast-enhanced pediatric cardiovascular MRI. Pediatr Radiol 41:1536–1544PubMedCentralPubMedCrossRef
20.
go back to reference Naehle CP, Kaestner M, Muller A et al (2010) First-pass and steady-state MR angiography of thoracic vasculature in children and adolescents. JACC Cardiovasc Imaging 3:504–513PubMedCrossRef Naehle CP, Kaestner M, Muller A et al (2010) First-pass and steady-state MR angiography of thoracic vasculature in children and adolescents. JACC Cardiovasc Imaging 3:504–513PubMedCrossRef
21.
go back to reference Boettcher J, Pfeil A, Wolf G et al (2013) Magnetic resonance venography of the upper venous system with blood pool contrast agent: comparison of two different T1-weighted sequences. Clin Imaging 37:245–250PubMedCrossRef Boettcher J, Pfeil A, Wolf G et al (2013) Magnetic resonance venography of the upper venous system with blood pool contrast agent: comparison of two different T1-weighted sequences. Clin Imaging 37:245–250PubMedCrossRef
22.
go back to reference Huang SY, Kim CY, Miller MJ et al (2013) Abdominopelvic and lower extremity deep venous thrombosis: evaluation with contrast-enhanced MR venography with a blood-pool agent. AJR Am J Roentgenol 201:208–214PubMedCrossRef Huang SY, Kim CY, Miller MJ et al (2013) Abdominopelvic and lower extremity deep venous thrombosis: evaluation with contrast-enhanced MR venography with a blood-pool agent. AJR Am J Roentgenol 201:208–214PubMedCrossRef
23.
go back to reference Pfeil A, Betge S, Poehlmann G et al (2012) Magnetic resonance VIBE venography using the blood pool contrast agent gadofosveset trisodium — an interrater reliability study. Eur J Radiol 81:547–552PubMedCrossRef Pfeil A, Betge S, Poehlmann G et al (2012) Magnetic resonance VIBE venography using the blood pool contrast agent gadofosveset trisodium — an interrater reliability study. Eur J Radiol 81:547–552PubMedCrossRef
24.
go back to reference Ghanouni P, Walters SG, Vasanawala SS (2012) Rapid MR venography in children using a blood pool contrast agent and multi-station fat-water-separated volumetric imaging. Pediatr Radiol 42:242–248PubMedCentralPubMedCrossRef Ghanouni P, Walters SG, Vasanawala SS (2012) Rapid MR venography in children using a blood pool contrast agent and multi-station fat-water-separated volumetric imaging. Pediatr Radiol 42:242–248PubMedCentralPubMedCrossRef
25.
go back to reference Stein PD, Chenevert TL, Fowler SE et al (2010) Gadolinium-enhanced magnetic resonance angiography for pulmonary embolism: a multicenter prospective study (PIOPED III). Ann Intern Med 152:434–443PubMedCentralPubMedCrossRef Stein PD, Chenevert TL, Fowler SE et al (2010) Gadolinium-enhanced magnetic resonance angiography for pulmonary embolism: a multicenter prospective study (PIOPED III). Ann Intern Med 152:434–443PubMedCentralPubMedCrossRef
26.
go back to reference Hansch A, Betge S, Poehlmann G et al (2011) Combined magnetic resonance imaging of deep venous thrombosis and pulmonary arteries after a single injection of a blood pool contrast agent. Eur Radiol 21:318–325PubMedCrossRef Hansch A, Betge S, Poehlmann G et al (2011) Combined magnetic resonance imaging of deep venous thrombosis and pulmonary arteries after a single injection of a blood pool contrast agent. Eur Radiol 21:318–325PubMedCrossRef
27.
go back to reference Pressacco J, Papas K (2012) Gadofosveset-enhanced magnetic resonance angiography as a means of evaluating pulmonary arteriovenous malformation: a case report. Magn Reson Imaging 30:886–888PubMedCrossRef Pressacco J, Papas K (2012) Gadofosveset-enhanced magnetic resonance angiography as a means of evaluating pulmonary arteriovenous malformation: a case report. Magn Reson Imaging 30:886–888PubMedCrossRef
28.
go back to reference Williams J, Vasanawala SS (2011) Active gastrointestinal hemorrhage identification by blood pool contrast-enhanced magnetic resonance angiography. Pediatr Radiol 41:1198–1200PubMedCrossRef Williams J, Vasanawala SS (2011) Active gastrointestinal hemorrhage identification by blood pool contrast-enhanced magnetic resonance angiography. Pediatr Radiol 41:1198–1200PubMedCrossRef
29.
go back to reference Jacobi B, Schubert T, Partovi S et al (2012) Gadofosveset — a blood pool contrast agent used with MRI to detect obscure gastrointestinal bleeding: a case report. Am J Gastroenterol 107:1107–1109PubMedCrossRef Jacobi B, Schubert T, Partovi S et al (2012) Gadofosveset — a blood pool contrast agent used with MRI to detect obscure gastrointestinal bleeding: a case report. Am J Gastroenterol 107:1107–1109PubMedCrossRef
30.
go back to reference Semionov A, Pressacco J (2011) Gadofosveset-enhanced 4D magnetic resonance angiography as a means of localizing the site of post aortic graft leak. Magn Reson Imaging 29:300–302PubMedCrossRef Semionov A, Pressacco J (2011) Gadofosveset-enhanced 4D magnetic resonance angiography as a means of localizing the site of post aortic graft leak. Magn Reson Imaging 29:300–302PubMedCrossRef
31.
go back to reference Milot L, Haider M, Foster L et al (2012) Gadofosveset trisodium in the investigation of focal liver lesions in noncirrhotic liver: early experience. J Magn Reson Imaging 36:738–742PubMedCrossRef Milot L, Haider M, Foster L et al (2012) Gadofosveset trisodium in the investigation of focal liver lesions in noncirrhotic liver: early experience. J Magn Reson Imaging 36:738–742PubMedCrossRef
Metadata
Title
Extracardiac applications of MR blood pool contrast agent in children
Authors
Shannon G. Farmakis
Geetika Khanna
Publication date
01-12-2014
Publisher
Springer Berlin Heidelberg
Published in
Pediatric Radiology / Issue 12/2014
Print ISSN: 0301-0449
Electronic ISSN: 1432-1998
DOI
https://doi.org/10.1007/s00247-014-3167-x

Other articles of this Issue 12/2014

Pediatric Radiology 12/2014 Go to the issue